HYLS1 Antikörper (AA 70-299)
-
- Target Alle HYLS1 Antikörper anzeigen
- HYLS1 (Hydrolethalus Syndrome 1 (HYLS1))
-
Bindungsspezifität
- AA 70-299
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HYLS1 Antikörper ist unkonjugiert
- Applikation
- Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human Hydrolethalus syndrome protein 1 protein (70-299AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- HYLS1 (Hydrolethalus Syndrome 1 (HYLS1))
- Andere Bezeichnung
- HYLS1 (HYLS1 Produkte)
- Synonyme
- HLS antikoerper, 3010015K02Rik antikoerper, HYLS1, centriolar and ciliogenesis associated antikoerper, HYLS1 antikoerper, Hyls1 antikoerper
- Hintergrund
-
Background: HYLS1, also named as HLS, is widely expressed in fetal tissue. Mutation of HYLS1 will cause the hydrolethalus syndrome (HLS) which is an autosomal recessive lethal malformation syndrome characterized by multiple developmental defects of fetus.
Aliases: HLS antibody, Hydrolethalus syndrome protein 1 antibody, HYLS1 antibody, HYLS1_HUMAN antibody
- UniProt
- Q96M11
-